NEW METHOD FOR STABILIZATION OF A BIOPHARMACEUTICAL MEDICINAL PRODUCT IN MANUFACTURE THEREOF Russian patent published in 2021 - IPC A61K39/395 A61K47/18 A61K47/26 A61K9/19 

Abstract RU 2744630 C2

FIELD: biopharmaceuticals.

SUBSTANCE: invention relates to a method of manufacture of a biopharmaceutical medicinal product containing the biomolecule of interest, wherein the method includes: (a) the first phase of manufacture of drug substance from the biomolecule of interest wherein said first phase includes at least one preparation stage chosen from harvest, enrichment wherein said at least one preparation stage in this first phase is conducted with a composition containing at least three amino acids wherein the combination of said at least three amino acids provides for at least one positively charged functional group, at least one antioxidant functional group, at least one osmolyte function and at least one buffer function; and (b) the second phase of further preparation of the drug substance developed in (a) to produce a biopharmaceutical medicinal product, wherein said second phase includes at least one preparation stage chosen from (b1) buffer replacement, (b2) freezing, (b3) unfreezing and (b4) filling; wherein at least one preparation stage at this second phase is conducted with a composition containing (i) at least three amino acids, wherein the combination of said at least three amino acids provides for at least one positively charged functional group, at least one antioxidant functional group, at least one osmolyte function and at least one buffer function; and (ii) one or several sugars, wherein the amino acid/sugar ratio is between 10:1 and 1:100 (in mass).

EFFECT: invention enables manufacture of a biopharmaceutical medicinal product containing the biomolecule of interest.

14 cl, 7 tbl, 30 dwg

Similar patents RU2744630C2

Title Year Author Number
LIQUID COMPOSITION OF POLYPEPTIDES CONTAINING FC DOMAIN OF IMMUNOGLOBULIN 2011
  • Tunga, Binita Shrivastava
  • Sharma, Sachin
  • Dua, Radzhiv
  • Dutta, Sourabkh
  • Mallubkhotla, Khanuman
  • Pandej, Vidzhajkant
  • Chatbar, Chandresh
RU2600847C2
PROTEIN POWDER COMPOSITIONS AND METHODS FOR PREPARING THEM 2009
  • Adler Mikhel'
  • Krauze Khans-Jurgen
  • Zidler Mikhel'
  • Lassner Peter
  • Li Dzheffri
RU2537139C2
STABLE PHARMACEUTICAL COMPOSITION 2017
  • Dzhajaraman Murali
  • Nair Pravin
  • Kanakadurga Lakshmi
  • Kaur Navnit
  • T Dipak
RU2736830C2
PHARMACEUTICAL COMPOSITION CONTAINING BIOPHARMACEUTICAL DRUG 2011
  • Danek-Bullius Marina
  • Dojtel Britta
  • Fyurtinger Sabina
  • Pragl Berndt
  • Kutsman Drago
RU2587056C2
PHARMACEUTICAL COMPOSITION CONTAINING ADALIMUMAB 2014
  • Fan Vejtsze
  • Van Khajbin
  • Tsyu Minkhun
  • Chzhen Khuntszyan
  • In Yuebin
  • Baj Khua
RU2664736C2
HIGHLY CONCENTRATED COMPOSITIONS OF MONOCLONAL ANTIBODIES 2013
  • Armstrong Nikolas Dzh.
  • Bauen Mayumi N.
  • Maa Yuj-Fan
RU2711089C2
SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODIES 2011
  • Igava Tomoyuki
  • Moriyama Tifumi
RU2653447C2
LIQUID PHARMACEUTICAL COMPOSITION 2015
  • Rinaldi Dzhanluka
  • Fratarkandzheli Silviya
  • Del Rio Alessandra
RU2719431C2
COMPOSITION OF CTLA-4 ANTIBODIES 2006
  • Ehbejt Dzhastin Donald
  • Das Tapan Kanti
  • Ehlliott Kehrri Mari
  • Mutkhurania Kevin Uomiti
  • Nema Sandip
  • Singkh Satish Kumar
RU2356579C1
PHARMACEUTICAL COMPOSITIONS OF HER2 ANTIBODY CONJUGATE 2020
  • Li, Chzhuanlin
  • Syuj, Tsyaoyuj
  • Yao, Syuetszin
  • Bao, Tsyantszin
  • Fan, Tszyanmin
RU2795196C2

RU 2 744 630 C2

Authors

Scholz, Martin

Kemter, Kristina

Altrichter, Jens

Kriehuber, Thomas

Dates

2021-03-12Published

2017-09-15Filed